Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.
Pichler R, Diem G, Hackl H, Koutník J, Mertens LS, D Andrea D, Pradere B, Soria F, Mari A, Laukhtina E, Krajewski W, Teoh JY, Del Guidice F, Moschini M, Thurnher M, Posch W. Pichler R, et al. Among authors: diem g. Front Immunol. 2023 Jul 13;14:1202157. doi: 10.3389/fimmu.2023.1202157. eCollection 2023. Front Immunol. 2023. PMID: 37520557 Free PMC article.
Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation.
Dichtl S, Diem G, Jäger M, Zaderer V, Lupoli G, Dächert C, Muenchhoff M, Graf A, Blum H, Keppler OT, Lass-Flörl C, Weiss G, Wilflingseder D, Posch W. Dichtl S, et al. Among authors: diem g. Antiviral Res. 2023 May;213:105581. doi: 10.1016/j.antiviral.2023.105581. Epub 2023 Mar 23. Antiviral Res. 2023. PMID: 36965526 Free PMC article.
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Lafon E, et al. Among authors: diem g. Front Immunol. 2021 Jun 14;12:684014. doi: 10.3389/fimmu.2021.684014. eCollection 2021. Front Immunol. 2021. PMID: 34194438 Free PMC article.
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern.
Diem G, Dichtl S, Zaderer V, Lass-Flörl C, Reindl M, Lupoli G, Dächert C, Muenchhoff M, Graf A, Blum H, Keppler OT, Wilflingseder D, Posch W. Diem G, et al. Microbiol Spectr. 2023 Aug 8;11(5):e0179323. doi: 10.1128/spectrum.01793-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37551989 Free PMC article.